Adenylyl cyclase type 5 inhibition to treat myocardial infarction
Ended Project Grant Awarded Last action
- Award ID
- R44HL142390
- Recipient
-
Vasade Biosciences Inc. UEI J66DCHJSKWA4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,495,601
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- New Jersey, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$64,980 | |
| Amendment | $40,028 | |
| Amendment | -$40,028 | |
| Amendment | $715,042 | |
| Amendment | $673,385 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $172,153 |
Quick answers
Who received award R44HL142390?
R44HL142390 was awarded to Vasade Biosciences Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2018.
How much is award R44HL142390 worth?
$1,495,601 has been obligated on R44HL142390.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award